{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:25:29Z","timestamp":1769304329558,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ad.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:01:54Z","timestamp":1412992914000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of the Efficacy and Safety of a Combination of 2 Topical Retinoids (RetinSphere) in Maintaining Post-Treatment Response of Acne to Oral Isotretinoin"],"prefix":"10.1016","volume":"106","author":[{"given":"M.T.","family":"Truchuelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mavura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ja\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2014.09.001_bib0005","first-page":"129","article-title":"Gu\u00edas colombianas para el manejo del acne: una revisi\u00f3n basada en la evidencia por el Grupo Colombiano de Estudio en Acne","volume":"19","author":"Orozco","year":"2011","journal-title":"Rev Asoc Colomb Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/0378-6323.86482","article-title":"Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial","volume":"77","author":"Agarwal","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2014.09.001_bib0015","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1468-3083.2010.03933.x","article-title":"Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission","volume":"25","author":"Borghi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2014.09.001_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a multicenter dose-response study","volume":"10","author":"Straus","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0025","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2010.06.025","article-title":"Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne?","volume":"65","author":"Coloe","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ad.2012.05.004","article-title":"Acne relapse rate and predictors of relapse following treatment with oral isotretinoin","volume":"104","author":"Morales-Cardona","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2014.09.001_bib0040","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2133.2007.08250.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","volume":"157","author":"Azoulay","year":"2007","journal-title":"Br J Dermatol"},{"issue":"5 Suppl.","key":"10.1016\/j.ad.2014.09.001_bib0045","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archderm.142.5.638","article-title":"Acne maintenance therapy: expanding the role of topical retinoids?","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000350820","article-title":"Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature","volume":"227","author":"Bettoli","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2014.09.001_bib0060","doi-asserted-by":"crossref","first-page":"736532","DOI":"10.1155\/2012\/736532","article-title":"Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use","volume":"2012","author":"Vender","year":"2012","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.ad.2014.09.001_bib0065","unstructured":"Guidance for Industry Acne Vulgaris: Developing Drugs for Treatment. 2005J:\\GUIDANC\\6499dftcln3.doc. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). September 2005. Clinical\/Medical."},{"key":"10.1016\/j.ad.2014.09.001_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2190\/FQXN-K610-BNY8-UQ0L","article-title":"Social sensitivity and acne: the role of personality in negative social consequences and quality of life","volume":"36","author":"Krejci-Manwaring","year":"2006","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.ad.2014.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-4632.2011.05409.x","article-title":"High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life","volume":"51","author":"Cyrulnik","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0080","first-page":"92","article-title":"An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acn\u00e9 vulgaris","volume":"70","author":"Saple","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2014.09.001_bib0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","article-title":"Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin","volume":"212","author":"Quereux","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2014.09.001_bib0090","first-page":"271","article-title":"Retinoides en dermatolog\u00eda","volume":"31","author":"Fernandez-Vozmedian","year":"2003","journal-title":"Med Cutan Iber Lat Am"},{"key":"10.1016\/j.ad.2014.09.001_bib0095","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0190-9622(98)70450-5","article-title":"The role of retinoids in wound healing","volume":"39","author":"Elson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D394Q2X8F1","article-title":"The potential immunomodulatory effects of topical retinoids (review)","volume":"11","author":"Jones","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2014.09.001_bib0105","first-page":"1","article-title":"Valutazione dell\u2019eficacia dell\u2019associazione di due retinoidi nel trattamento dell\u2019acne lieve-moderata","volume":"14","author":"Fabbrocini","year":"2012","journal-title":"Esper Dermatol"},{"key":"10.1016\/j.ad.2014.09.001_bib0110","first-page":"13","article-title":"Treatment of comedonal-papular mild acne with a fixed combination of hydroxypinacolone retinoate, retinol glycospheres and papain glycospheres. Preliminary results of a sponsor-free, pilot, open multicentre study","volume":"3","author":"Veraldi","year":"2012","journal-title":"Eur J Acne Relat Dis"},{"key":"10.1016\/j.ad.2014.09.001_bib0115","unstructured":"DATA ON FILE 2008: TOPICAL HYDROXYPINACOLONE RETINOATE Skin Diffusion, Receptor Activity, Metabolism and Mildness. John Gormley. Grant Industries Inc. 2008."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731014004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:02:59Z","timestamp":1757552579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731014004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0001731014004128"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2014.09.001","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the Efficacy and Safety of a Combination of 2 Topical Retinoids (RetinSphere) in Maintaining Post-Treatment Response of Acne to Oral Isotretinoin","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}